These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 34065907)
1. The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development. Zhou Z; Zhu J; Jiang M; Sang L; Hao K; He H Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065907 [TBL] [Abstract][Full Text] [Related]
2. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids. Ayyar VS; Jusko WJ Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034 [TBL] [Abstract][Full Text] [Related]
3. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study. Yoon M; Kedderis GL; Yan GZ; Clewell HJ Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738 [TBL] [Abstract][Full Text] [Related]
4. Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration. Yu J; Cilfone NA; Large EM; Sarkar U; Wishnok JS; Tannenbaum SR; Hughes DJ; Lauffenburger DA; Griffith LG; Stokes CL; Cirit M CPT Pharmacometrics Syst Pharmacol; 2015 Oct; 4(10):585-94. PubMed ID: 26535159 [TBL] [Abstract][Full Text] [Related]
5. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen. Loisios-Konstantinidis I; Cristofoletti R; Jamei M; Turner D; Dressman J Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33147873 [TBL] [Abstract][Full Text] [Related]
6. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research. Poulin P; Burczynski FJ; Haddad S J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749 [TBL] [Abstract][Full Text] [Related]
7. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms. Boger E; Fridén M J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860 [TBL] [Abstract][Full Text] [Related]
8. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing. Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390 [TBL] [Abstract][Full Text] [Related]
9. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction. Lee-Montiel FT; Laemmle A; Charwat V; Dumont L; Lee CS; Huebsch N; Okochi H; Hancock MJ; Siemons B; Boggess SC; Goswami I; Miller EW; Willenbring H; Healy KE Front Pharmacol; 2021; 12():667010. PubMed ID: 34025426 [TBL] [Abstract][Full Text] [Related]
10. A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification. Moj D; Britz H; Burhenne J; Stewart CF; Egerer G; Haefeli WE; Lehr T Cancer Chemother Pharmacol; 2017 Nov; 80(5):1013-1026. PubMed ID: 28988277 [TBL] [Abstract][Full Text] [Related]
11. Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model. Singh AP; Zheng X; Lin-Schmidt X; Chen W; Carpenter TJ; Zong A; Wang W; Heald DL MAbs; 2020; 12(1):1688616. PubMed ID: 31852337 [TBL] [Abstract][Full Text] [Related]
12. Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment. Jaroch K; Jaroch A; Bojko B J Pharm Biomed Anal; 2018 Jan; 147():297-312. PubMed ID: 28811111 [TBL] [Abstract][Full Text] [Related]
13. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology. Watson DE; Hunziker R; Wikswo JP Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799 [TBL] [Abstract][Full Text] [Related]
14. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development. Raasch M; Fritsche E; Kurtz A; Bauer M; Mosig AS Adv Drug Deliv Rev; 2019 Feb; 140():51-67. PubMed ID: 29908880 [TBL] [Abstract][Full Text] [Related]
15. Human Microphysiological Systems and Organoids as Truskey GA Front Public Health; 2018; 6():185. PubMed ID: 30042936 [TBL] [Abstract][Full Text] [Related]
16. Next generation organoids for biomedical research and applications. Lou YR; Leung AW Biotechnol Adv; 2018; 36(1):132-149. PubMed ID: 29056474 [TBL] [Abstract][Full Text] [Related]
17. Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products. Ibarra M; Valiante C; Sopeña P; Schiavo A; Lorier M; Vázquez M; Fagiolino P Eur J Pharm Sci; 2018 Jun; 118():176-182. PubMed ID: 29605455 [TBL] [Abstract][Full Text] [Related]
18. Imaging microphysiological systems: a review. Peel S; Jackman M Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942 [TBL] [Abstract][Full Text] [Related]
19. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272 [TBL] [Abstract][Full Text] [Related]
20. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling. Eglen RM; Reisine T SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]